• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 POS filed by Humana Inc.

    12/19/25 4:57:12 PM ET
    $HUM
    Medical Specialities
    Health Care
    Get the next $HUM alert in real time by email
    S-8 POS 1 dp238793_s8pos.htm FORM S-8 POS

     

    As filed with the Securities and Exchange Commission on December 19, 2025 

    Registration No. 333-264543

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

     

    POST-EFFECTIVE AMENDMENT NO. 1

    TO

     

    FORM S-8

     

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

     

     

    HUMANA INC.

    (Exact name of registrant as specified in its Charter)

     

    Delaware   61-0647538
    (State or other jurisdiction of
    incorporation or organization)
     

    (IRS. Employer 

    Identification No.) 

     

    500 West Main Street
    Louisville, Kentucky 40202
    (502) 580-1000

    (Address of Principal Executive Offices, Zip Code)

     

    Humana Retirement Savings Plan

    Humana Savings & Investment Plan 

    (Full title of the plan)

     

     

     

    Joseph C. Ventura
    Chief Legal Officer
    Humana Inc.
    500 West Main Street
    Louisville, Kentucky 40202
    (914) 253-2000 

    (Name and address and telephone number,
    including area code, of agent for service)

     

     

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

     

    Large accelerated filer ☒   Accelerated filer ☐
    Non-accelerated filer ☐   Smaller reporting company ☐
    Emerging growth company ☐      

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act of 1933, as amended (the “Securities Act”).   ☐

     

     

     

    EXPLANATORY NOTE

     

    On April 28, 2022, Humana Inc. (the “Registrant”) filed a Registration Statement on Form S-8 (Registration No. 333-264543) (the “2022  Registration Statement”) with the Securities and Exchange Commission (the “SEC”) to register 5,000,000 additional shares of the Registrant’s common stock (the “Common Stock”) for issuance under the Registrant’s Humana Retirement Savings Plan (the “Savings Plan”), with the 2022 Registration Statement incorporating the Registrant’s registration statement on Form S-8 filed with the SEC on October 29, 2009 (Registration No. 333-162747).  The Registrant paid a registration fee of $202,331.66 at that time to register the securities.  An indeterminate amount of interests to be offered and sold was also registered.  

     

    Effective December 31, 2025 (the “Effective Date”), the Savings Plan spun-off the Humana Savings & Investment Plan (the “HSIP”)  (the “Spin”). Pursuant to the Spin, a portion of the Common Stock previously registered and authorized for issuance under the Savings Plan became eligible for issuance under the HSIP. As of the Effective Date, there were 120,000 shares of Common Stock previously registered and authorized for issuance under the Savings Plan that are now eligible for issuance under the HSIP (the “Spin-Off Shares”).  

     

    Accordingly, pursuant to the undertaking in Item 512(a)(1)(iii) of Regulation S-K that the Registrant disclose a material change in the plan of distribution as it was originally disclosed in the 2022 Registration Statement, the Registrant is filing this Post-Effective Amendment No. 1 to the 2022 Registration Statement to reflect that, as of the Effective Date, the Spin-Off Shares will be available for issuance under the HSIP.

     

     

     

    PART I 

    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

     

    Item 1. Plan Information.*

     

    Item 2. Registrant Information and Employee Plan Annual Information.*

     

    * Information required by Part I to be contained in the Section 10(a) prospectus is omitted from this Registration Statement in accordance with Rule 428 under the Securities Act and the Note to Part I of Form S-8.

     

    PART II 

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

     

    Item 3. Incorporation of Documents by Reference.

     

    The SEC allows us to “incorporate by reference” information into this Registration Statement, which means that the Registrant can disclose important information to you by referring you to documents that we file with the SEC. The information incorporated by reference is considered to be part of this Registration Statement, and later information that the Registrant files with the SEC will automatically update this Registration Statement. We incorporate by reference the documents listed below and any future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (other than, in each case, documents or information deemed to have been furnished and not filed in accordance with SEC rules), on or after the date of this Registration Statement and before the filing of any post-effective amendment to this Registration Statement which deregisters all such securities then remaining unsold:

     

      (a)

    The Registrant’s Annual Report filed on Form 10-K for the year ended December 31, 2024, filed on February 20, 2025, which contains the Registrant’s audited consolidated financial statements for the fiscal year ended December 31, 2024;

     

      (b)

    all other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the Registrant’s Annual Report referred to in (a) above;

     

      (c)

    the description of the Registrant’s common stock, par value $0.16-2/3 per share, contained in the Registrant’s Registration Statement on Form 8-A/A filed with the SEC on March 1, 1999; and

     

      (d) Annual Report of the Humana Retirement Savings Plan on Form 11-K for the fiscal year ended December 31, 2024.
     

    All documents filed by the Registrant pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the filing of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing such documents, except as to specific sections of such documents as set forth therein. Unless expressly incorporated into this Registration Statement, a report furnished on Form 8-K prior or subsequent to the filing of this Registration Statement shall not be deemed incorporated by reference into this Registration Statement. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained in any subsequently filed document that also is deemed to be incorporated by reference herein modifies or supersedes such statement.

     

    Item 4. Description of Securities.

     

    Not applicable.

     

    Item 5. Interests of Named Experts and Counsel.

     

    The validity of the issuance of the shares of Common Stock being offered by the Registration Statement will be passed upon for the Registrant by Joseph C. Ventura, Chief Legal Officer of the Registrant. As of  December 18, 2025, Mr. Ventura owned 8,971 shares of Common Stock, has the equivalent of 290 shares of Common Stock in the Savings Plan, and also has exercisable stock options to purchase 18,150 shares of Common Stock of the Registrant.

     

     

     

    Item 6. Indemnification of Directors and Officers.

     

    The Registrant’s Restated Certificate of Incorporation and bylaws, as amended, include provisions to (i) eliminate the personal liability of its directors for monetary damages resulting from breaches of their fiduciary duty to the extent permitted by Section 102(b)(7) of the General Corporation Law of Delaware (the “Delaware Law”) and (ii) authorize the Registrant to indemnify its directors and officers to the fullest extent permitted by Section 145 of the Delaware Law, including circumstances in which indemnification is otherwise discretionary.

     

    Pursuant to Section 145 of the Delaware Law, a corporation generally has the power to indemnify its present and former directors, officers, employees and agents against expenses incurred by them in connection with any suit to which they are, or are threatened to be made, a party by reason of their serving in such positions so long as they acted in good faith and in a manner they reasonably believed to be in, or not opposed to, the best interests of a corporation, and with respect to any criminal action, they had no reasonable cause to believe their conduct was unlawful. The Registrant believes that these provisions are necessary to attract and retain qualified persons as directors and officers. These provisions do not eliminate liability for breach of the director’s duty of loyalty to the Registrant or its stockholders, for acts or omissions not in good faith or involving intentional misconduct or knowing violations of law, for any transaction from which the director derived an improper personal benefit or for any willful or negligent payment of any unlawful dividend or any unlawful stock purchase or redemption.

     

    The Registrant has entered into agreements with its directors and executive officers that require the Registrant to indemnify such persons against expenses, judgments, fines, settlements and other amounts actually and reasonably incurred (including expenses of a derivative action) in connection with any proceeding, whether actual or threatened, to which any such person may be made a party by reason of the fact that such person is or was a director or officer of the Registrant or any of its affiliates, provided such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Registrant and, with respect to any criminal proceeding, had no reasonable cause to believe his or her conduct was unlawful. The indemnification agreements also set forth certain procedures that will apply in the event of a claim for indemnification thereunder.

     

    The Registrant has also purchased an insurance policy covering the officers and directors of the Registrant with respect to certain liabilities arising under the Securities Act.

     

    Item 7. Exemption from Registration Claimed.

     

    Not applicable.

     

    Item 8. Exhibits.

     

    Exhibit Index

     

    The following is a list of the exhibits filed as part of this Post-Effective Amendment No. 1 to Form S-8.

     

    Exhibit   Incorporated by Reference Filed
    Number Exhibit Description Form File No. Exhibit Filing Date Herewith
                 
    4.1 Restated Certificate of Incorporation filed with the Secretary of State of
    Delaware on November 9, 1989, as restated to incorporate the amendment
    of January 9, 1992, and the correction of March 23, 1992
    S-8 033-49305 4(i) February 2, 1994  
                 
    4.2 By-Laws of Humana Inc., as amended on December 14, 2017 8-K 001-05975 3(b)

    December 14, 2017

     

     
                 
    4.3 Form of Registrant’s Common Stock certificate 8-A/A 001-05975 4.3 March 1, 1999  
                 
    5.1 Opinion of counsel as to the validity of the securities registered herein.         X
                 
    23.1 Consent of PricewaterhouseCoopers LLP, independent registered public
    accounting firm for the Registrant.
            X
                 
    23.2 Consent of counsel (included in the opinion filed as Exhibit 5.1)         X
                 
    24.1 Powers of Attorney (included on the signature page of this Registration Statement         X
                 
    99.1 Humana Retirement Savings Plan (as amended) S-8 333-264543 99.1 April 28, 2022  
                 
    99.2 Humana Savings & Investment Plan         X

     

    In lieu of an opinion of counsel concerning compliance with the requirements of the Employee Retirement Income Security Act of 1974, as amended, and an Internal Revenue Service (“IRS”) determination letter that the Savings Plan and the HSIP are each qualified under Section 401 of the Internal Revenue Code, the Registrant hereby undertakes that it will submit or has submitted each of the Savings Plan and the HSIP and any amendment thereto to the IRS in a timely manner and has made or will make all changes required by the IRS in order to qualify each of the Savings Plan and the HSIP.

     

     

     

    Item 9. Undertakings.

     

    1.The undersigned registrant hereby undertakes:

     

    (a)To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

     

    (i)To include any prospectus required by Section 10(a)(3) of the Securities Act;

     

    (ii)To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement; and

     

    (iii)To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement;

     

    provided, however, that paragraphs (1)(a)(i) and (1)(a)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.

     

    (b)That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; and

     

    (c)To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

     

    2.The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of such registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

    3.Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

     

    [SIGNATURES ON THE NEXT PAGE]

     

     

     

    SIGNATURES

     

    Signature   Title   Date
             
    /s/ CELESTE M. MELLET   Chief Financial Officer   December 19, 2025
    Celeste M. Mellet   (Principal Financial Officer)    
             
    /s/ JOHN-PAUL W. FELTER   Senior Vice President,
    Chief Accounting Officer and Controller
      December 19, 2025
    John-Paul W. Felter   (Principal Accounting Officer)    
             
    /s/ JAMES A. RECHTIN   President and Chief Executive Officer, Director   December 19, 2025
    James A. Rechtin   (Principal Executive Officer)    
             
    /s/ KURT J. HILZINGER   Chairman of the Board   December 19, 2025
    Kurt J. Hilzinger        
             
    /s/ RAQUEL C. BONO, M.D.   Director   December 19, 2025
    Raquel C. Bono, M.D.        
             
    /s/ FRANK A. D’AMELIO   Director   December 19, 2025
    Frank A. D’Amelio        
             
    /s/ WAYNE A. I. FREDERICK, M.D.   Director   December 19, 2025
    Wayne A. I. Frederick, M.D.        
             
    /s/ DAVID T. FEINBERG, M.D.   Director   December 19, 2025
    David T. Feinberg, M.D.        
             
    /s/ JOHN W. GARRATT   Director   December 19, 2025
    John W. Garratt        
             
    /s/ KAREN W. KATZ   Director   December 19, 2025
    Karen W. Katz        
             
    /s/ MARCY S. KLEVORN   Director   December 19, 2025
    Marcy S. Klevorn        
             
    /s/ JORGE S. MESQUITA   Director   December 19, 2025
    Jorge S. Mesquita        
             
    /s/ GORDON SMITH   Director   December 19, 2025
    Gordon Smith        
             

     

    The Registrant. Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to the Form S-8 Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Louisville, the Commonwealth of Kentucky, on December 19, 2025.

     

      HUMANA INC.
       
      By: /s/ CELESTE M. MELLET
      Name: Celeste M. Mellet
      Title: Chief Financial Officer
    (Principal Financial Officer)

     

     

     

    KNOW ALL MEN BY THESE PRESENTS, Each person whose signature appears below constitutes and appoints James A. Rechtin, Celeste M. Mellet and John-Paul W. Felter, and each of them, his or her true and lawful attorneys-in-fact and agents, with full power of substitution to execute in his or her name and on his or her behalf, and to file any amendments (including, without limitation, post-effective amendments) to this Registration Statement necessary or advisable in the opinion of any of them to enable the Company to comply with the Securities Act, and any rules, regulations and requirements of the Securities and Exchange Commission thereunder, in connection with the registration of the additional securities which are under the subject of this Registration Statement.

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, this Post-Effective Amendment No. 1 to the Form S-8 Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

     

    Signature   Title   Date
             
    /s/ CELESTE M. MELLET   Chief Financial Officer   December 19, 2025
    Celeste M. Mellet   (Principal Financial Officer)    
             
    /s/ JOHN-PAUL W. FELTER   Senior Vice President,
    Chief Accounting Officer and Controller
      December 19, 2025
    John-Paul W. Felter   (Principal Accounting Officer)    
             
    /s/ JAMES A. RECHTIN   President and Chief Executive Officer, Director   December 19, 2025
    James A. Rechtin   (Principal Executive Officer)    
             
    /s/ KURT J. HILZINGER   Chairman of the Board   December 19, 2025
    Kurt J. Hilzinger        
             
    /s/ RAQUEL C. BONO, M.D.   Director   December 19, 2025
    Raquel C. Bono, M.D.        
             
    /s/ FRANK A. D’AMELIO   Director   December 19, 2025
    Frank A. D’Amelio        
             
    /s/ WAYNE A. I. FREDERICK, M.D.   Director   December 19, 2025
    Wayne A. I. Frederick, M.D.        
             
    /s/ DAVID T. FEINBERG, M.D.   Director   December 19, 2025
    David T. Feinberg, M.D.        
             
    /s/ JOHN W. GARRATT   Director   December 19, 2025
    John W. Garratt        
             
    /s/ KAREN W. KATZ   Director   December 19, 2025
    Karen W. Katz        
             
    /s/ MARCY S. KLEVORN   Director   December 19, 2025
    Marcy S. Klevorn        
             
    /s/ JORGE S. MESQUITA   Director   December 19, 2025
    Jorge S. Mesquita        
             
    /s/ GORDON SMITH   Director   December 19, 2025
    Gordon Smith        

     

     

     

    The Plan.  Pursuant to the requirements of the Securities Act of 1933, as amended, the administrators of Humana Retirement Savings Plan and Humana Savings & Investment Plan has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Louisville, the Commonwealth of Kentucky, on the 19th day of December, 2025.

     

      HUMANA RETIREMENT SAVINGS PLAN
       
      /s/ JESSICA KLEIN
      Name: Jessica Klein
      Title: SVP, Total Rewards, on behalf of Humana Retirement Savings Plan Committee

     

     

      HUMANA SAVINGS & INVESTMENT PLAN
       
      /s/ JESSICA KLEIN
      Name: Jessica Klein
      Title: SVP, Total Rewards, on behalf of Humana Retirement Savings Plan Committee

     

     

    Get the next $HUM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HUM

    DatePrice TargetRatingAnalyst
    1/7/2026$290.00Overweight → Equal Weight
    Wells Fargo
    12/5/2025$313.00Hold → Buy
    Jefferies
    10/14/2025$235.00Sell
    Goldman
    9/22/2025$295.00In-line
    Evercore ISI
    5/1/2025$315.00Mkt Perform → Outperform
    Raymond James
    11/6/2024$247.00 → $308.00Underperform → Neutral
    BofA Securities
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    10/8/2024$308.00Mkt Perform → Outperform
    Bernstein
    More analyst ratings

    $HUM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Humana Inc. to Release Fourth Quarter 2025 Results on February 11, 2026

    Humana Inc. (NYSE:HUM) will release its financial results for the fourth quarter 2025 (4Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on February 11, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 4Q25 earnings call may be accessed via Humana's Investor Relations page at https://humana.gcs-web.com/. If you anticipate asking a question during the question-and-answer session, please register in advance using this link, https://register-conf.media-server.com/register/BIb3f01f81dd3b4f7cb8331d38dad89

    1/9/26 6:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana, Nurses on Boards Coalition Announce New Partnership to Mentor Emerging Nurses

    Humana has announced a new partnership with the national Nurses on Boards Coalition (NOBC) to provide mentors for nursing students. Humana is providing a gift of $110,000 for first-year funding to support the NOBC's Mentoring for Success program, which will match 50 nursing students with 50 mentors who work as nurses for Humana. The mentoring program gets underway in early 2026. Humana would then continue funding the program at $90,000 per year after that. With its gift, Humana becomes a founding partner of the mentoring initiative and now has a leadership seat on the program's advisory board impact group. "Humana employs more than 10,000 nurses, including many in our CenterWell health c

    12/17/25 11:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    AM Best Affirms Credit Ratings of Humana Inc. and Its Subsidiaries

    AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) for the health and dental insurance subsidiaries of Humana Inc. (Humana) (headquartered in Louisville, KY) (NYSE:HUM). These subsidiaries collectively are referred to as Humana Health Group. In addition, AM Best has affirmed the Long-Term ICR of "bbb" (Good) and the Long-Term Issue Credit Ratings (Long-Term IRs) of Humana Inc. (Humana). AM Best also has affirmed the Short-Term Issue Credit Rating of AMB-2 (Satisfactory) for Humana. The outlook of these Credit Ratings (ratings) is stable. (See below for a detailed listing of Humana Health Group

    12/16/25 5:31:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Humana downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Humana from Overweight to Equal Weight and set a new price target of $290.00

    1/7/26 8:56:48 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana upgraded by Jefferies with a new price target

    Jefferies upgraded Humana from Hold to Buy and set a new price target of $313.00

    12/5/25 8:31:42 AM ET
    $HUM
    Medical Specialities
    Health Care

    Goldman initiated coverage on Humana with a new price target

    Goldman initiated coverage of Humana with a rating of Sell and set a new price target of $235.00

    10/14/25 8:50:11 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Financials

    Live finance-specific insights

    View All

    Humana Inc. to Release Fourth Quarter 2025 Results on February 11, 2026

    Humana Inc. (NYSE:HUM) will release its financial results for the fourth quarter 2025 (4Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on February 11, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 4Q25 earnings call may be accessed via Humana's Investor Relations page at https://humana.gcs-web.com/. If you anticipate asking a question during the question-and-answer session, please register in advance using this link, https://register-conf.media-server.com/register/BIb3f01f81dd3b4f7cb8331d38dad89

    1/9/26 6:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    AM Best Affirms Credit Ratings of Humana Inc. and Its Subsidiaries

    AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) for the health and dental insurance subsidiaries of Humana Inc. (Humana) (headquartered in Louisville, KY) (NYSE:HUM). These subsidiaries collectively are referred to as Humana Health Group. In addition, AM Best has affirmed the Long-Term ICR of "bbb" (Good) and the Long-Term Issue Credit Ratings (Long-Term IRs) of Humana Inc. (Humana). AM Best also has affirmed the Short-Term Issue Credit Rating of AMB-2 (Satisfactory) for Humana. The outlook of these Credit Ratings (ratings) is stable. (See below for a detailed listing of Humana Health Group

    12/16/25 5:31:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Reports Third Quarter 2025 Financial Results; Affirms Full Year 2025 Adjusted EPS Guidance

    Reports 3Q25 earnings per share (EPS) of $1.62 on a GAAP basis, Adjusted EPS of $3.24; reports YTD EPS of $16.43 on a GAAP basis, $21.10 on an Adjusted basis 3Q25 Insurance segment benefit ratio of 91.1 percent, in line with the company's previously disclosed expectation of 'just above 91 percent' Updates FY 2025 GAAP EPS guidance to 'approximately $12.26' from the previous estimate of 'approximately $13.77'; affirms Adjusted FY 2025 EPS guidance of 'approximately $17.00' Affirms FY 2025 Insurance segment benefit ratio guidance range of 90.1 percent to 90.5 percent Updates FY 2025 individual Medicare Advantage membership guidance to now anticipate a decline of 'approximately 425,00

    11/5/25 6:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Feinberg David T was granted 766 units of Humana Common, increasing direct ownership by 174% to 1,207 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    1/5/26 2:29:49 PM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form 4 filed by Director Frederick Wayne A.I.

    4 - HUMANA INC (0000049071) (Issuer)

    1/5/26 2:19:08 PM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form 4 filed by Director Garratt John W

    4 - HUMANA INC (0000049071) (Issuer)

    1/5/26 1:52:53 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    SEC Filings

    View All

    SEC Form S-8 POS filed by Humana Inc.

    S-8 POS - HUMANA INC (0000049071) (Filer)

    12/19/25 4:57:12 PM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HUMANA INC (0000049071) (Filer)

    12/16/25 8:05:45 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - HUMANA INC (0000049071) (Filer)

    12/1/25 7:30:38 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/16/24 4:29:43 PM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/14/24 10:02:59 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/13/24 5:06:27 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Rechtin James A. bought $1,496,984 worth of Humana Common (6,530 units at $229.25) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    5/16/25 4:48:13 PM ET
    $HUM
    Medical Specialities
    Health Care

    Mesquita Jorge S. bought $200,066 worth of Humana Common (545 units at $367.09) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/21/24 10:37:23 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Leadership Updates

    Live Leadership Updates

    View All

    Humana Announces Insurance Leadership Transition

    George Renaudin to Retire as Insurance Segment President by Q3 2026 Aaron Martin to Join as President of Medicare Advantage and Insurance Segment President Successor John Barger to Succeed Martin as President of Medicare Advantage Humana Inc. (NYSE:HUM) today announced that George Renaudin, Insurance Segment President and member of Humana's Enterprise Leadership Team, will retire by Q3 2026 following a successful 29-year career at the company. During this period, Renaudin played a pivotal role in establishing and growing Humana's Medicare Advantage and Medicaid programs, helping to build them into high-performing businesses and assembling a strong insurance leadership team. "George has co

    12/16/25 8:05:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    National Mall of Pickleball Returns for Third Year with Expanded Footprint and New, Central Location

    The National Mall of Pickleball will celebrate America's most accessible sport and the game that serves all in the heart of the National Mall this September The Trust for the National Mall, Humana (NYSE:HUM), and the Humana Foundation announced today that the highly-anticipated National Mall of Pickleball is returning to America's Front Yard, the National Mall, for a third year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625316935/en/ From Friday, September 19 through Sunday, September 21, 2025, the general public can experience a weekend full of pickleball programming, activities, and community with captivating views o

    6/25/25 9:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Launches "Invite" Campaign to Inspire Active Aging Through Pickleball and Community Connection

    Humana Inc. (NYSE:HUM), a leading health and well-being company, is expanding its commitment to senior wellness with the launch of Invite, a new campaign designed to encourage older adults of all fitness levels to stay active, connected and engaged – starting with the fastest-growing sport in America: pickleball. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250618737488/en/As part of Humana's new "Invite" campaign, the health and wellness company debuted a television spot featuring senior pickleball athletes extending an open invitation to others to join the fun, stay social, and support their physical and mental well-being. A

    6/18/25 8:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care